eCAP – improving the outcomes of GERD patients in Europe and beyond
Gastrointestinal diseases, which range from functional problems to cancers, are among the most common medical ailments across the globe.
Many digestive diseases are difficult to diagnose as the symptoms are vague and variable. Moreover, currently available diagnostic tools require highly skilled interpretation and high set-up cost.
eCAP smart capsule, implanted by minimally invasive techniques, will allow gastrointestinal physiology monitoring for a longer, controlled period of time.
With the inclusion of accurate real-time patient experience data and interpretation guided by Artificial Intelligence, GERD diagnostics will be cheaper, faster, and more robust.
Improved patient outcomes
achieved through timely and accurate diagnosis
Enhanced access to digestive disease diagnostics and care
enabled by decreased cost of equipment and expertise required from the physician for data interpretation
Decreased care costs
on the patient and system level
Patient empowerment
supported by user-friendly medical devices and inclusion of patient-reported symptoms in diagnosis